Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples